Keisuke Nakatsuka Selected Research

Keisuke Nakatsuka Research Topics

2	Mixed Connective Tissue Disease (MCTD) 07/2023 - 11/2022
2	Pulmonary Arterial Hypertension 07/2023 - 11/2022
2	Interstitial Lung Diseases (Interstitial Lung Disease) 07/2023 - 06/2002
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2005 - 10/2003
1	Myositis (Idiopathic Inflammatory Myopathies) 07/2023
1	Immunoglobulin G4-Related Disease 01/2022
1	Churg-Strauss Syndrome (Allergic Angiitis) 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Carcinoma (Carcinomatosis) 01/2016
1	Confusion (Bewilderment) 10/2004
1	Neurogenic Urinary Bladder (Bladder, Neurogenic) 10/2004
1	Muscle Weakness 10/2004
1	Myelitis 10/2004
1	Purpura 02/2004
1	Arthritis (Polyarthritis) 02/2004
1	Chronic Hepatitis (Chronic Active Hepatitis) 02/2004
1	Infections 02/2004
1	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 12/2003
1	Sjogren's Syndrome (Sjogren Syndrome) 12/2003
1	Skin Ulcer 12/2003
1	Vasculitis (Vasculitides) 12/2003
1	Hemolytic Anemia 10/2003
1	Mononeuropathies (Mononeuritis Multiplex) 06/2002
1	Cystitis 06/2002

2	AntibodiesIBA 07/2023 - 11/2022
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2004 - 10/2003
2	SteroidsIBA 10/2004 - 10/2003
2	Prednisolone (Predate)FDA LinkGeneric 10/2004 - 02/2004
1	Biomarkers (Surrogate Marker)IBA 07/2023
1	SMN Complex ProteinsIBA 07/2023
1	Immunoglobulin G (IgG)IBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2016
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2005
1	CryoglobulinsIBA 02/2004
1	RNA (Ribonucleic Acid)IBA 02/2004
1	Antirheumatic Agents (DMARD)IBA 02/2004
1	mizoribineIBA 12/2003
1	Alprostadil (Muse)FDA LinkGeneric 12/2003
1	Oxygen (Dioxygen)IBA 12/2003
1	DNA (Deoxyribonucleic Acid)IBA 10/2003
1	ImmunosorbentsIBA 10/2003
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 10/2003
1	Antinuclear AntibodiesIBA 10/2003
1	Anti-Bacterial Agents (Antibiotics)IBA 06/2002
1	Rheumatoid FactorIBA 06/2002